Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034709 · ClinicalTrials.gov registry record
Evaluation of the Artus® CMV PCR Test
A clinical trial of Cytomegalovirus Infections, sponsored by QIAGEN Gaithersburg.
- Completed
- Registry status
- 111
- Enrollment target
- 5
- Study locations
NCT01034709 is a study of Cytomegalovirus Infections that has completed, run by QIAGEN Gaithersburg. The registered enrollment target is 111 participants, below the 198-participant average among 24 other Cytomegalovirus Infections trials with a reported enrollment target (44% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT01034709, a study of Cytomegalovirus Infections, has completed, sponsored by QIAGEN Gaithersburg.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
- 5
- Study locations
Study Summary
Subjects with symptomatic CMV infection, who are enrolled in this clinical study, will be monitored during antiviral therapy.
Conditions Studied
Study Locations (5)
Florida
- University of Miami - Miami
- LifeLink Health Care Institute - Tampa
California
- University of California - Los Angeles - Los Angeles
Georgia
- Emory University Hospital - Atlanta
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2009-12 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01034709
The ClinicalTrials.gov registry entry for NCT01034709 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 198-participant average among 24 other Cytomegalovirus Infections trials with a reported enrollment target (44% lower). The listed sponsor is QIAGEN Gaithersburg, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cytomegalovirus Infections appearing as the primary indexed condition, and to 0 interventions.
NCT01034709 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT01034709 about?
NCT01034709 is a clinical study titled "Evaluation of the Artus® CMV PCR Test". Subjects with symptomatic CMV infection, who are enrolled in this clinical study, will be monitored during antiviral therapy.
What is the current status of trial NCT01034709?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2009-12. Estimated completion is 2014-06.
What conditions does trial NCT01034709 study?
This clinical trial studies the following conditions: Cytomegalovirus Infections.
Who is sponsoring clinical trial NCT01034709?
This trial is sponsored by QIAGEN Gaithersburg, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01034709 being conducted?
This trial has 5 study locations across California, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cytomegalovirus Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
RECRUITING · Phase 4
-
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
RECRUITING · Phase 2
-
Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
RECRUITING
-
R-MVST Cells for Treatment of Viral Infections
RECRUITING · Phase 1
-
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
RECRUITING · Phase 1
-
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.